Atlas Trials

Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid

Clinical trial NCT01409811 · TERMINATED

Trial details

NCT number
NCT01409811
Sponsor
City of Hope Medical Center
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Estrogen Receptor-positive Breast CancerInvasive Ductal Breast CarcinomaProgesterone Receptor-positive Breast CancerStage IA Breast CancerStage IB Breast CancerStage IIA Breast CancerStage IIB Breast Cancer
Start date
2012-09-14
Primary completion
2015-01-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.